View Cart (0 items)


GlaxoSmithKline to acquire Genelabs Technologies

November 3, 2008
GlaxoSmithKline will acquire Genelabs Technologies Inc. for $57 million. The company said the deal will strengthen Glaxo''s effort to develop treatments for the hepatitis C virus. Under the terms
Read More

Charles River expands to China

October 16, 2008 reports that Charles River Laboratories International has opened a new research facility in China. The company announced that the 60,000-square-foot building in Shanghai was open for business. An increasing
Read More

ImClone accepts $6 billion-plus buyout bid from Lilly

October 6, 2008
According to the Associated Press, Eli Lilly & Co. has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that will expand Lilly''s
Read More

Teva and Kowa to create Japanese generic maker

September 30, 2008
Teva Pharmaceutical Industries Ltd. will team with Kowa Co. to create a generic drug maker in Japan, according to the Associated Press. Teva-Kowa Pharma Co. will be owned equally
Read More

FDA reviews experimental use of anemia drugs in stroke patients after report on death rates

September 30, 2008
Federal health regulators are reviewing the experimental use of blockbuster anemia drugs made by Amgen and Johnson & Johnson that has been associated with higher death rates in a study
Read More

Brazil to make AIDS drug after Merck talks fail

September 18, 2008
Brazil''s health minister says Latin America''s biggest country will produce an inexpensive generic version of an AIDS drug made by Merck & Co., according to the Associated Press. Production should begin in
Read More

Pfizer osteoporosis drug leads to deaths, FDA concerned

September 11, 2008
Federal regulators say a drug from Pfizer and Ligand Pharmaceuticals effectively treats osteoporosis, though they are concerned about deaths, blood clots and other problems seen in company studies, as reported
Read More

Medivation wins potential $725M deal with Pfizer

September 4, 2008
Pfizer Inc. will pay $225 million upfront in a development and commercialization deal for San Francisco-based Medivation Inc.’s late-stage Alzheimer’s disease and Huntington’s disease treatment, according to Medivation could
Read More

Zentiva rejects Sanofi Aventis bid

July 21, 2008
The board of Czech generic drugs maker Zentiva N.V. has recommended that its shareholders reject a takeover offer from French pharmaceuticals maker Sanofi-Aventis SA, the Associated Press reports. On July
Read More

U.S. authority seeks documents from India''s Ranbaxy

July 14, 2008
According to Reuters, the U.S. Food and Drug Administration has filed a motion in a U.S. court seeking documents from Indian drugmaker Ranbaxy Laboratories Ltd as part of an ongoing
Read More